Iovance Biotherapeutics I...

NASDAQ: IOVA · Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.98%
After-hours: Aug 15, 2025, 04:10 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-372.18M -444.04M -395.89M -342.25M
Depreciation & Amortization
43.61M 33.13M 21.14M 13.98M
Stock-Based Compensation
109.63M 62.63M 84.02M 69.77M
Other Working Capital
-5.61M -1.08M -8.78M 17.58M
Other Non-Cash Items
-8.65M -3.54M 871K 6.01M
Deferred Income Tax
-2.83M -3.48M n/a n/a
Change in Working Capital
-122.56M -6.52M -2.89M 24.55M
Operating Cash Flow
-352.98M -361.82M -292.76M -227.94M
Capital Expenditures
-11.07M -22.29M -20.43M -37.57M
Cash Acquisitions
-52.57M -212.63M -276.88M -37.71M
Purchase of Investments
-460.77M -205.9M -245.82M -725.21M
Sales Maturities Of Investments
428M 285.58M 522.7M 762.91M
Other Investing Acitivies
n/a n/a 276.88M 37.71M
Investing Cash Flow
-96.41M -155.24M 256.45M 132K
Debt Repayment
n/a n/a n/a 1M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-6.64M -322K 648K 35.11M
Financial Cash Flow
390.66M 462.96M 190.15M 239.27M
Net Cash Flow
-59.27M -56.84M 153.85M 11.46M
Free Cash Flow
-364.05M -384.11M -313.18M -265.51M